NM_024675.4(PALB2):c.1396T>C (p.Ser466Pro) AND Hereditary cancer-predisposing syndrome

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Apr 1, 2023
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003311297.2

Allele description [Variation Report for NM_024675.4(PALB2):c.1396T>C (p.Ser466Pro)]

NM_024675.4(PALB2):c.1396T>C (p.Ser466Pro)

Gene:

PALB2:partner and localizer of BRCA2 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

16p12.2

Genomic location:

Preferred name:

NM_024675.4(PALB2):c.1396T>C (p.Ser466Pro)

HGVS:

NC_000016.10:g.23635150A>G
NG_007406.1:g.11208T>C
NM_001407296.1:c.1336T>C
NM_001407297.1:c.1396T>C
NM_001407298.1:c.1396T>C
NM_001407299.1:c.1396T>C
NM_001407300.1:c.1396T>C
NM_001407301.1:c.1396T>C
NM_001407302.1:c.1396T>C
NM_001407304.1:c.511T>C
NM_001407305.1:c.511T>C
NM_001407306.1:c.511T>C
NM_001407307.1:c.511T>C
NM_001407308.1:c.511T>C
NM_001407309.1:c.511T>C
NM_001407310.1:c.511T>C
NM_001407311.1:c.511T>C
NM_001407312.1:c.-104-4681T>C
NM_001407313.1:c.-104-4681T>C
NM_001407314.1:c.49-5875T>C
NM_024675.4:c.1396T>CMANE SELECT
NP_001394225.1:p.Ser446Pro
NP_001394226.1:p.Ser466Pro
NP_001394227.1:p.Ser466Pro
NP_001394228.1:p.Ser466Pro
NP_001394229.1:p.Ser466Pro
NP_001394230.1:p.Ser466Pro
NP_001394231.1:p.Ser466Pro
NP_001394233.1:p.Ser171Pro
NP_001394234.1:p.Ser171Pro
NP_001394235.1:p.Ser171Pro
NP_001394236.1:p.Ser171Pro
NP_001394237.1:p.Ser171Pro
NP_001394238.1:p.Ser171Pro
NP_001394239.1:p.Ser171Pro
NP_001394240.1:p.Ser171Pro
NP_078951.2:p.Ser466Pro
NP_078951.2:p.Ser466Pro
LRG_308t1:c.1396T>C
LRG_308:g.11208T>C
LRG_308p1:p.Ser466Pro
NC_000016.9:g.23646471A>G
NM_024675.3:c.1396T>C

Protein change:

S171P

Molecular consequence:

NM_001407312.1:c.-104-4681T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_001407313.1:c.-104-4681T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_001407314.1:c.49-5875T>C - intron variant - [Sequence Ontology: SO:0001627]
NM_001407296.1:c.1336T>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001407297.1:c.1396T>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001407298.1:c.1396T>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001407299.1:c.1396T>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001407300.1:c.1396T>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001407301.1:c.1396T>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001407302.1:c.1396T>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001407304.1:c.511T>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001407305.1:c.511T>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001407306.1:c.511T>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001407307.1:c.511T>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001407308.1:c.511T>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001407309.1:c.511T>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001407310.1:c.511T>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001407311.1:c.511T>C - missense variant - [Sequence Ontology: SO:0001583]
NM_024675.4:c.1396T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Hereditary cancer-predisposing syndrome
Synonyms:: Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:: MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Clear Turn Off Turn On

rap guanine nucleotide exchange factor 1 isoform X22 [Mus musculus]
rap guanine nucleotide exchange factor 1 isoform X22 [Mus musculus]
gi|1720396649|ref|XP_030102347.1|

Protein

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004007887	Ambry Genetics	criteria provided, single submitter (Ambry Variant Classification Scheme 2023)	Uncertain significance (Apr 1, 2023)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004007887

Ambry Genetics

criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)

Uncertain significance
(Apr 1, 2023)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Ambry Genetics, SCV004007887.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

The p.S466P variant (also known as c.1396T>C), located in coding exon 4 of the PALB2 gene, results from a T to C substitution at nucleotide position 1396. The serine at codon 466 is replaced by proline, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: May 1, 2024

ClinVar

Relating variation to medicine